Literature DB >> 23995583

Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats.

Aram Parsegian1, Ronald E See2.   

Abstract

Methamphetamine (meth) addicts often exhibit enduring cognitive and neural deficits that likely contribute to persistent drug seeking and the high rates of relapse. These deficits may be related to changes in the prefrontal cortex (PFC) and its glutamatergic projections to the nucleus accumbens (NAc). Here, we performed in vivo microdialysis in the PFC and NAc in rats following either meth self-administration or yoked-saline control histories to assess baseline glutamate (GLU) levels, or reinstatement-evoked GLU and dopamine (DA) efflux in both regions simultaneously under cue-induced, meth-primed, or combined cues+meth reinstatement conditions. Our results show that meth self-administration (1) reduced basal GLU levels in both the dmPFC and NAc, (2) concurrently increased dmPFC and NAc GLU efflux during reinstatement, and (3) increased DA efflux in the dmPFC, but not in the NAc, under all reinstatement conditions when compared with yoked-saline controls. These data demonstrate for the first time that a history of psychostimulant self-administration alters GLU homeostasis not only in the NAc, but also in the dmPFC, its primary GLU projection source. Furthermore, combined cues+meth-primed reinstatement conditions produced the most pronounced increases in mPFC and NAc extracellular GLU, suggesting that the cue and meth prime conditions are additive in promoting reinstatement. Finally, increased efflux of DA in the dmPFC, but not in the NAc, across reinstatement conditions suggests that DA release in the dmPFC may be an important mediator of drug seeking initiated by multiple relapse triggers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995583      PMCID: PMC3924513          DOI: 10.1038/npp.2013.231

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  56 in total

Review 1.  Drug addiction as dopamine-dependent associative learning disorder.

Authors:  G Di Chiara
Journal:  Eur J Pharmacol       Date:  1999-06-30       Impact factor: 4.432

Review 2.  Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission.

Authors:  P W Kalivas; N Volkow; J Seamans
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

3.  Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters.

Authors:  H M Haughey; J M Brown; D G Wilkins; G R Hanson; A E Fleckenstein
Journal:  Brain Res       Date:  2000-04-28       Impact factor: 3.252

4.  Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons.

Authors:  D B Carr; S R Sesack
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 5.  The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans.

Authors:  D Ongür; J L Price
Journal:  Cereb Cortex       Date:  2000-03       Impact factor: 5.357

6.  Distinct neurochemical adaptations within the nucleus accumbens produced by a history of self-administered vs non-contingently administered intravenous methamphetamine.

Authors:  Kevin D Lominac; Arianne D Sacramento; Karen K Szumlinski; Tod E Kippin
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

7.  Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction.

Authors:  Nora D Volkow; Gene-Jack Wang; Yeming Ma; Joanna S Fowler; Christopher Wong; Yu-Shin Ding; Robert Hitzemann; James M Swanson; Peter Kalivas
Journal:  J Neurosci       Date:  2005-04-13       Impact factor: 6.167

8.  Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm.

Authors:  Osama A Abulseoud; Joseph D Miller; Jinhua Wu; Doo-Sup Choi; Daniel P Holschneider
Journal:  Brain Res       Date:  2012-03-27       Impact factor: 3.252

9.  Relapse induced by cues predicting cocaine depends on rapid, transient synaptic potentiation.

Authors:  Cassandra D Gipson; Yonatan M Kupchik; Haowei Shen; Kathryn J Reissner; Charles A Thomas; Peter W Kalivas
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

10.  Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats.

Authors:  Marek Schwendt; Carmela M Reichel; Ronald E See
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

View more
  48 in total

1.  Methamphetamine blunts Ca(2+) currents and excitatory synaptic transmission through D1/5 receptor-mediated mechanisms in the mouse medial prefrontal cortex.

Authors:  Betina González; Celeste Rivero-Echeto; Javier A Muñiz; Jean Lud Cadet; Edgar García-Rill; Francisco J Urbano; Verónica Bisagno
Journal:  Addict Biol       Date:  2015-04-14       Impact factor: 4.280

2.  β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors.

Authors:  Lauren M Slosky; Yushi Bai; Krisztian Toth; Caroline Ray; Lauren K Rochelle; Alexandra Badea; Rahul Chandrasekhar; Vladimir M Pogorelov; Dennis M Abraham; Namratha Atluri; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick Maloney; Hong Yuan; Zibo Li; William C Wetsel; Anthony B Pinkerton; Lawrence S Barak; Marc G Caron
Journal:  Cell       Date:  2020-05-28       Impact factor: 41.582

3.  Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats.

Authors:  P S S Rao; S Goodwani; R L Bell; Y Wei; S H S Boddu; Y Sari
Journal:  Neuroscience       Date:  2015-03-24       Impact factor: 3.590

4.  Effects of Methamphetamine Self-Administration and Extinction on Astrocyte Structure and Function in the Nucleus Accumbens Core.

Authors:  B M Siemsen; C M Reichel; K C Leong; C Garcia-Keller; C D Gipson; S Spencer; J A McFaddin; K N Hooker; P W Kalivas; M D Scofield
Journal:  Neuroscience       Date:  2019-03-26       Impact factor: 3.590

5.  Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly.

Authors:  Karen K Szumlinski; Kevin D Lominac; Rianne R Campbell; Matan Cohen; Elissa K Fultz; Chelsea N Brown; Bailey W Miller; Sema G Quadir; Douglas Martin; Andrew B Thompson; Georg von Jonquieres; Matthias Klugmann; Tamara J Phillips; Tod E Kippin
Journal:  Biol Psychiatry       Date:  2016-10-13       Impact factor: 13.382

6.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

7.  Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex.

Authors:  V Echeverry-Alzate; E Giné; K M Bühler; J Calleja-Conde; P Olmos; M A Gorriti; R Nadal; F Rodríguez de Fonseca; J A López-Moreno
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 8.  Chronic methamphetamine self-administration disrupts cortical control of cognition.

Authors:  Aurelien Bernheim; Ronald E See; Carmela M Reichel
Journal:  Neurosci Biobehav Rev       Date:  2016-07-20       Impact factor: 8.989

9.  Methamphetamine reduces expression of caveolin-1 in the dorsal striatum: Implication for dysregulation of neuronal function.

Authors:  Sucharita S Somkuwar; McKenzie J Fannon; Brian P Head; Chitra D Mandyam
Journal:  Neuroscience       Date:  2016-04-30       Impact factor: 3.590

10.  Prefrontal glutamate correlates of methamphetamine sensitization and preference.

Authors:  Kevin D Lominac; Sema G Quadir; Hannah M Barrett; Courtney L McKenna; Lisa M Schwartz; Paige N Ruiz; Melissa G Wroten; Rianne R Campbell; Bailey W Miller; John J Holloway; Katherine O Travis; Ganesh Rajasekar; Dan Maliniak; Andrew B Thompson; Lawrence E Urman; Tod E Kippin; Tamara J Phillips; Karen K Szumlinski
Journal:  Eur J Neurosci       Date:  2016-02-22       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.